CORVEL CORP (CRVL) Stock Fundamental Analysis
NASDAQ:CRVL - Nasdaq - US2210061097 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to CRVL. CRVL was compared to 103 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CRVL a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, CRVL is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year CRVL was profitable.
CRVL had a positive operating cash flow in the past year.
Each year in the past 5 years CRVL has been profitable.
In the past 5 years CRVL always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 17.43%, CRVL belongs to the top of the industry, outperforming 97.09% of the companies in the same industry.
CRVL's Return On Equity of 29.56% is amongst the best of the industry. CRVL outperforms 94.17% of its industry peers.
CRVL has a better Return On Invested Capital (28.08%) than 96.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRVL is significantly above the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.43% | ||
| ROE | 29.56% | ||
| ROIC | 28.08% |
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
1.3 Margins
Looking at the Profit Margin, with a value of 10.63%, CRVL belongs to the top of the industry, outperforming 95.15% of the companies in the same industry.
CRVL's Profit Margin has improved in the last couple of years.
CRVL has a Operating Margin of 13.49%. This is amongst the best in the industry. CRVL outperforms 84.47% of its industry peers.
In the last couple of years the Operating Margin of CRVL has grown nicely.
Looking at the Gross Margin, with a value of 23.44%, CRVL is in line with its industry, outperforming 48.54% of the companies in the same industry.
CRVL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.49% | ||
| PM (TTM) | 10.63% | ||
| GM | 23.44% |
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
2. Health
2.1 Basic Checks
CRVL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CRVL has about the same amount of shares outstanding.
The number of shares outstanding for CRVL has been reduced compared to 5 years ago.
CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 19.23 indicates that CRVL is not in any danger for bankruptcy at the moment.
The Altman-Z score of CRVL (19.23) is better than 96.12% of its industry peers.
CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 19.23 |
ROIC/WACC3.14
WACC8.93%
2.3 Liquidity
CRVL has a Current Ratio of 1.90. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.
CRVL's Current ratio of 1.90 is fine compared to the rest of the industry. CRVL outperforms 71.84% of its industry peers.
A Quick Ratio of 1.90 indicates that CRVL should not have too much problems paying its short term obligations.
The Quick ratio of CRVL (1.90) is better than 73.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
CRVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.05%, which is quite impressive.
CRVL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.86% yearly.
Looking at the last year, CRVL shows a quite strong growth in Revenue. The Revenue has grown by 12.61% in the last year.
CRVL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.62% yearly.
EPS 1Y (TTM)26.05%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%37.38%
Revenue 1Y (TTM)12.61%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%11.72%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
CRVL is valuated quite expensively with a Price/Earnings ratio of 56.51.
CRVL's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.45, CRVL is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 56.51 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRVL is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as CRVL.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 57.68 | ||
| EV/EBITDA | 33.99 |
4.3 Compensation for Growth
CRVL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.35
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CRVL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
102.85
+1.46 (+1.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners53.89%
Inst Owner Change0.3%
Ins Owners7.2%
Ins Owner Change-0.53%
Market Cap5.28B
Analysts0
Price TargetN/A
Short Float %3.09%
Short Ratio5.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 56.51 | ||
| Fwd PE | N/A | ||
| P/S | 5.9 | ||
| P/FCF | 57.68 | ||
| P/OCF | 41.48 | ||
| P/B | 16.4 | ||
| P/tB | 18.55 | ||
| EV/EBITDA | 33.99 |
EPS(TTM)1.82
EY1.77%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.78
FCFY1.73%
OCF(TTM)2.48
OCFY2.41%
SpS17.44
BVpS6.27
TBVpS5.54
PEG (NY)N/A
PEG (5Y)3.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.43% | ||
| ROE | 29.56% | ||
| ROCE | 35.34% | ||
| ROIC | 28.08% | ||
| ROICexc | 56.04% | ||
| ROICexgc | 71.6% | ||
| OM | 13.49% | ||
| PM (TTM) | 10.63% | ||
| GM | 23.44% | ||
| FCFM | 10.22% |
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
ROICexc(3y)48.46%
ROICexc(5y)45.93%
ROICexgc(3y)62.9%
ROICexgc(5y)61.44%
ROCE(3y)35.98%
ROCE(5y)33.03%
ROICexcg growth 3Y4.75%
ROICexcg growth 5Y18.9%
ROICexc growth 3Y6.87%
ROICexc growth 5Y18.29%
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
F-Score8
Asset Turnover1.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 121.06% | ||
| Cap/Sales | 3.99% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 84.67% | ||
| Profit Quality | 96.21% | ||
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.9 | ||
| Altman-Z | 19.23 |
F-Score8
WACC8.93%
ROIC/WACC3.14
Cap/Depr(3y)112.41%
Cap/Depr(5y)107.09%
Cap/Sales(3y)3.78%
Cap/Sales(5y)3.81%
Profit Quality(3y)90.78%
Profit Quality(5y)99.01%
High Growth Momentum
Growth
EPS 1Y (TTM)26.05%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%37.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.61%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%11.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.05%
EBIT growth 3Y12.65%
EBIT growth 5Y14.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.81%
FCF growth 3Y34.78%
FCF growth 5Y13.57%
OCF growth 1Y28.29%
OCF growth 3Y23.73%
OCF growth 5Y9.51%